Cas:186022-53-7 Desmethylcarfentanil acid manufacturer & supplier

We serve Chemical Name:Desmethylcarfentanil acid CAS:186022-53-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Desmethylcarfentanil acid

Chemical Name:Desmethylcarfentanil acid
CAS.NO:186022-53-7
Synonyms:Desmethylcarfentanil acid
Molecular Formula:C23H28N2O3
Molecular Weight:380.48000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:60.85000
Exact Mass:380.21000
LogP:3.52940

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Desmethylcarfentanil acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Desmethylcarfentanil acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Desmethylcarfentanil acid Use and application,Desmethylcarfentanil acid technical grade,usp/ep/jp grade.


Related News: Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend. Desmethylcarfentanil acid manufacturer At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. Desmethylcarfentanil acid supplier Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend. Desmethylcarfentanil acid vendor At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. Desmethylcarfentanil acid factory In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said.